[Treatment of chronic myeloid leukemia and lymphoreticular sarcoma with piposulfan].
D000328:Adult; D000368:Aged; D000741:Anemia, Aplastic / Q000139:chemically induced; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002066:Busulfan / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use*; D013921:Thrombocytopenia / Q000139:chemically induced
D000970:Antineoplastic Agents; D010879:Piperazines; D002066:Busulfan
Die Behandlung der chronischen myeloischen Leukämie und des lymphoretikulären Sarkoms mit Piposulfan.